Application of nanotechnology to cancer radiotherapy

被引：84
作者：
Mi Y. [1 ,2 ]
Shao Z. [3 ]
Vang J. [1 ,2 ]
Kaidar-Person O. [1 ,2 ]
Wang A.Z. [1 ,2 ]
机构：
[1] Laboratory of Nano- and Translational Medicine, Lineberger Comprehensive Cancer Center, Carolina Center for Cancer Nanotechnology Excellence, Carolina Institute of Nanomedicine, University of North Carolina at Chapel Hill, Chapel Hill, 27599, NC
[2] Department of Radiation Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, 27599, NC
[3] Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute, Xuzhou Medical College, Xuzhou
来源：
Cancer Nanotechnology | 2016年 / 7卷 / 1期
基金：
美国国家卫生研究院;
关键词：
Cancer nanotechnology; Combination therapy; Image-guided radiotherapy; Radioisotope; Radiosensitizer; Radiotherapy;
D O I：
10.1186/s12645-016-0024-7
中图分类号：
学科分类号：
摘要：
Radiotherapy has been an integral treatment modality for cancer. The field arose from and progressed through innovations in physics, engineering, and biology. The evolution of radiation oncology will rely on the continued adoption of advances from other fields. A new area of science that possesses the ability to impact radiation oncology is nanomedicine. Materials on the nanoscale provide many unique properties such as enhanced permeability and retention effect and superparamagnetism that are well suited for applications in radiation oncology. In this review, we will provide a comprehensive summary on how nanotechnology can improve cancer radiotherapy in aspects of treatment delivery and monitoring as well as diagnosis. © 2016, The Author(s).
引用
收藏
相关论文
共 86 条
[11]  
Brigger I., Dubernet C., Couvreur P., Nanoparticles in cancer therapy and diagnosis, Adv Drug Deliv Rev, 54, 5, pp. 631-651, (2002)
[12]  
Brizel D.M., Sibley G.S., Prosnitz L.R., Scher R.L., Dewhirst M.W., Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck, Int J Radiat Oncol Biol Phys, 38, 2, pp. 285-289, (1997)
[13]  
Carmeliet P., Jain R.K., Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases, Nat Rev Drug Discov, 10, 6, pp. 417-427, (2011)
[14]  
Davis M.E., Chen Z.G., Shin D.M., Nanoparticle therapeutics: an emerging treatment modality for cancer, Nat Rev Drug Discov, 7, 9, pp. 771-782, (2008)
[15]  
Dinniwell R., Chan P., Czarnota G., Haider M.A., Jhaveri K., Jewett M., Milosevic M., Pelvic lymph node topography for radiotherapy treatment planning from ferumoxtran-10 contrast-enhanced magnetic resonance imaging, Int J Radiat Oncol Biol Phys, 74, 3, pp. 844-851, (2009)
[16]  
Dipetrillo T., Milas L., Evans D., Akerman P., Ng T., Miner T., Safran H., Paclitaxel poliglumex (PPX-Xyotax) and concurrent radiation for esophageal and gastric cancer: a phase I study, Am J Clin Oncol, 29, 4, pp. 376-379, (2006)
[17]  
Dong W., Li Y., Niu D., Ma Z., Gu J., Chen Y., Shi J., Facile synthesis of monodisperse superparamagnetic Fe<sub>3</sub>O<sub>4</sub> Core@ hybrid@ Au shell nanocomposite for bimodal imaging and photothermal therapy, Adv Mater, 23, 45, pp. 5392-5397, (2011)
[18]  
Dykman L., Khlebtsov N., Gold nanoparticles in biomedical applications: recent advances and perspectives, Chem Soc Rev, 41, 6, pp. 2256-2282, (2012)
[19]  
Eblan M.J., Wang A.Z., Improving chemoradiotherapy with nanoparticle therapeutics, Transl Cancer Res, 2, 4, pp. 320-329, (2013)
[20]  
Fan W., Shen B., Bu W., Chen F., Zhao K., Zhang S., Shi J., Rattle-structured multifunctional nanotheranostics for synergetic chemo-/radiotherapy and simultaneous magnetic/luminescent dual-mode imaging, J Am Chem Soc, 135, 17, pp. 6494-6503, (2013)
123456789